Creative Diagnostics on Twitter: "Tumor Marker Antigens Tumor markers are substances either produced by tumor cells (tumor-derived) or by the body in response to tumor cells (tumor-associated), which can aid cancer detection
![IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite](https://www.mdpi.com/ijms/ijms-19-01162/article_deploy/html/images/ijms-19-01162-sch003.png)
IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite
![The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients. | Semantic Scholar The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f9fe9b0551ba8982cad417e64a1fe8413f9bd5c5/2-Table1-1.png)
The relation between tumor marker Ca 15-3 and metastases in interpectoral lymph nodes in breast cancer patients. | Semantic Scholar
![Tumor marker CA 19.9 and CEA studies, with TNM staging at presentation | Download Scientific Diagram Tumor marker CA 19.9 and CEA studies, with TNM staging at presentation | Download Scientific Diagram](https://www.researchgate.net/publication/342853002/figure/tbl2/AS:911956965851136@1594438892266/Tumor-marker-CA-199-and-CEA-studies-with-TNM-staging-at-presentation_Q640.jpg)
Tumor marker CA 19.9 and CEA studies, with TNM staging at presentation | Download Scientific Diagram
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
![Table 1 from Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Semantic Scholar Table 1 from Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5d6f060039736a337655ff8c37f0605527be3327/2-Table1-1.png)
Table 1 from Level and evaluation of tumor marker CA-125 in ovarian cancer patients in Khyber Pakhtunkhwa, Pakistan. | Semantic Scholar
![Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/5/2711/F1.large.jpg)
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research
![The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology](https://cdn.amegroups.cn/journals/pbpc/files/journals/1/articles/181/public/181-PB15-4535-R1.png/w300)